Treatment of Nocturnal Gout Attacks
For acute gout attacks causing nighttime pain, initiate treatment immediately with NSAIDs at full anti-inflammatory doses (such as naproxen or indomethacin), oral corticosteroids (prednisone 0.5 mg/kg/day), or low-dose colchicine (1.2 mg followed by 0.6 mg one hour later), and continue treatment until the attack completely resolves. 1, 2
Immediate Treatment Approach
First-Line Monotherapy Options
Treatment must be initiated within 24 hours of symptom onset for optimal effectiveness - delaying beyond this window significantly reduces treatment success. 1, 2
Choose one of the following based on patient comorbidities:
NSAIDs at full FDA-approved doses (naproxen, indomethacin, or sulindac) continued until complete resolution of the attack 1, 2
Oral corticosteroids: Prednisone 0.5 mg/kg per day for 5-10 days at full dose, then stop; or 2-5 days at full dose followed by 7-10 day taper 1, 2
Low-dose colchicine: 1.2 mg followed by 0.6 mg one hour later (maximum 1.8 mg in first 12 hours), then 0.6 mg twice daily starting at least 12 hours after initial dose 1, 2
Combination Therapy for Severe Attacks
For severe nocturnal pain or polyarticular involvement (≥4 joints), combination therapy should be initiated immediately with any of the following: 1, 2
- Colchicine plus NSAIDs 1
- Oral corticosteroids plus colchicine 1
- Intra-articular steroids (for 1-2 affected joints) combined with any other systemic modality 1
Do NOT combine NSAIDs with systemic corticosteroids due to synergistic gastrointestinal toxicity risk. 1
Critical Management Principles
Never interrupt ongoing urate-lowering therapy (allopurinol, febuxostat) during the acute attack - discontinuation worsens outcomes 1, 2, 4
Continue initial treatment at full dose until the gouty attack has completely resolved, not just until pain improves 1
Inadequate response is defined as <20% improvement in pain within 24 hours or <50% improvement after 24 hours - if this occurs, add a second appropriate agent 1, 2
Adjunctive Non-Pharmacologic Measures
- Apply topical ice to the affected joint as an adjunctive measure during acute attacks 2, 5
- Rest the inflamed joint 5
Prophylaxis to Prevent Future Nocturnal Attacks
If not already on prophylaxis, initiate anti-inflammatory prophylaxis with or just prior to starting urate-lowering therapy: 1, 2
First-Line Prophylactic Options:
- Low-dose colchicine 0.6 mg once or twice daily (adjusted for renal function and drug interactions) 1, 2
- Low-dose NSAIDs (e.g., naproxen 250 mg twice daily) with proton pump inhibitor where indicated 1, 2
Second-Line Prophylactic Option:
- Low-dose prednisone (<10 mg/day) if colchicine and NSAIDs are contraindicated, not tolerated, or ineffective 1, 2
Duration of Prophylaxis:
Continue for the greater of: 1, 2
- At least 6 months, OR
- 3 months after achieving target serum urate (<6 mg/dL) if no tophi present, OR
- 6 months after achieving target serum urate if tophi are present
Common Pitfalls to Avoid
Delaying treatment beyond 24 hours dramatically reduces effectiveness of all agents 1, 2
Stopping urate-lowering therapy during acute attacks - this is a critical error that worsens disease control 1, 2, 4
Failing to provide prophylaxis when initiating or adjusting urate-lowering therapy - this leads to acute flares and poor medication adherence 2, 4
Using high-dose colchicine regimens - the traditional high-dose approach causes significantly more gastrointestinal side effects without additional benefit 1, 2
Inadequate fluid intake - maintain daily urinary output of at least 2 liters to prevent xanthine calculi and help prevent renal urate precipitation 4